Titre : | Strategies for evaluating the economic value of drugs in alcohol dependence treatment (2012) |
Auteurs : | D. SCHWAPPACH ; S. POPOVA ; S. MOHAPATRA ; J. PATRA ; A. GODINHO ; J. REHM |
Type de document : | Article : Périodique |
Dans : | Drug and Alcohol Dependence (Vol.122, n°3, May 2012) |
Article en page(s) : | 165-173 |
Langues: | Anglais |
Discipline : | TRA (Traitement et prise en charge / Treatment and care) |
Mots-clés : |
Thésaurus mots-clés ANTABUSE ; COUT ; COUT SOCIAL ; EFFICACITE ; ACAMPROSATE ; ALCOOL ; NALTREXONE ; TRAITEMENT ; EPIDEMIOLOGIE ANALYTIQUEThésaurus géographique BELGIQUE ; ESPAGNE ; ETATS-UNIS ; ALLEMAGNE ; AUSTRALIE |
Résumé : | BACKGROUND. To assess existing health economic strategies, which are used to evaluate the economic value of drugs to treat alcohol dependence (AD) such as acamprosate, naltrexone and any other pharmaceuticals. METHODS. A systematic literature search on AD treatment economic evaluation studies was performed in multiple electronic bibliographic and economic databases. RESULTS. A total of seven studies were found that involved economic evaluations of pharmacotherapy treatment of AD. It was seen that all individual pharmacotherapy treatment programs including acamprosate, naltrexone and combined treatments have resulted in a net benefit or cost savings. However, the examined studies used different methods to estimate the costs, cost savings, and cost effectiveness of the treatments. CONCLUSIONS. Pharmacotherapy treatment of AD produced marked economic benefits. However, the number of studies on the economic evaluation of pharmacotherapy for AD treatment is limited. The gaps in these studies have also been identified as necessitating more research. |
Domaine : | Alcool / Alcohol |
Sous-type de document : | Revue de la littérature / Literature review |
Refs biblio. : | 34 |
Affiliation : | Research Institute for Public Health and Addiction, WHO Collaborating Centre for Substance Abuse, Suisse |
Accueil